VivoSim Labs, Inc. Equity Securities, FV-NI
VivoSim Labs, Inc. (VIVS) had Equity Securities, FV-NI of $0 as of 2024-03-31, per its 10-K filed 2024-05-31.
Discontinued › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments › Short-Term Investments
us-gaap:EquitySecuritiesFvNi · last filed 2024-05-31
- 2024-03-31: Equity Securities, FV-NI $0.00.
- 2023-12-31: Equity Securities, FV-NI $0.00.
- 2023-09-30: Equity Securities, FV-NI $0.00.
- 2023-06-30: Equity Securities, FV-NI $0.00.
| Period end | Equity Securities, FV-NI |
|---|---|
| 2024-03-31 | $0.00 10-K · filed 2024-05-31 |
| 2023-12-31 | $0.00 10-Q · filed 2024-02-08 |
| 2023-09-30 | $0.00 10-Q · filed 2023-11-09 |
| 2023-06-30 | $0.00 10-Q · filed 2023-08-10 |
| 2023-03-31 | $700.00K 10-K · filed 2023-07-14 |
| 2022-12-31 | $600.00K 10-Q · filed 2023-02-09 |
| 2022-09-30 | $600.00K 10-Q · filed 2022-11-10 |
| 2022-06-30 | $723.00K 10-Q · filed 2022-08-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |